Next-Generation HDAC6 Inhibitors (Karus Therapeutics)

N/A

Report date: 2025/01/26 15:53:21

NME

Base Information

Drug NameNext-Generation HDAC6 Inhibitors (Karus Therapeutics)

Drug Alias Namehistone deacetylase 6 inhibitors (Karus Therapeutics)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistone deacetylase 6 inhibitors

TargetsHistone deacetylase 6

Therapy Area/IndicationsGlioblastomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUruguay

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsNeoplasms

ATC CodeN/A